Kimberly-Clark Q2 Earnings Rise Y/Y, Gross Margin Expands
Kimberly-Clark (KMB) reported Q2 2026 adjusted EPS of $2.12, up 10.4% y/y, and sales of $4,189 million, up 0.6% but below the $4,232 million Zacks estimate. Adjusted gross margin rose 190 bps to 38.8%. The company forecasts 2026 organic sales growth about 100 bps below category growth, with mid-single-digit adjusted operating profit growth.
How this was made
The 30-second read
Why it matters
Near-term sentiment hinges on whether the market treats the China diaper disruption as temporary versus persistent, given management expects it to continue affecting sales and profits in the near term. Margin expansion and productivity savings provide a counterweight.
Market read
A trader can update positioning based on the combination of margin/profit strength, the sales miss, and management’s explicit expectation that the China disruption will keep pressuring near-term sales and profits.
What to watch
The guidance revision is quantified as about 100 bps of companywide impact from the China social media disruption, and segment operating profit trends differ (NA profit up, IPC profit up despite disruption).
Background
The article summarizes Kimberly-Clark’s Q2 2026 results, including adjusted EPS, sales versus consensus, margin drivers, segment performance, and updated 2026 expectations.
Ticker impact
Kimberly-Clark reported Q2 adjusted EPS of $2.12 (up 10.4% Y/Y) and expanded adjusted gross margin to 38.8%, but sales missed consensus.
Likely choppy post-earnings trading, with upside bias if investors focus on margin/profit strength and downside risk if they anchor on the sales miss and ongoing China disruption.
The article provides both upside (EPS growth, gross margin +190 bps, operating profit +6.2%) and downside (sales miss, organic sales -0.1%, guidance revised for China disruption).
Market effects
Signals resilience in consumer staples margins via productivity and tariff refunds, while highlighting operational/geopolitical disruption risk in personal care categories.
China diaper business disruption is explicitly called out as a continuing headwind affecting sales and profits near term.
Currency benefits and divestiture drag underscore how global FX and portfolio actions can swing reported growth versus organic trends.
Counterpoint
Investors may over-penalize the sales miss because adjusted gross margin and operating profit improved, suggesting cost actions are offsetting demand softness.
Key entities
- companyKimberly-Clark Corporation
Reported Q2 2026 results with adjusted EPS growth, gross margin expansion, and a sales miss versus consensus, plus guidance reflecting ongoing China disruption.
